Treace Medical Concepts (TMCI) Return on Capital Employed (2021 - 2026)
Treace Medical Concepts (TMCI) posted Return on Capital Employed of 36.47% for Q1 2026, down 9.73% on a QoQ basis from 33.23% in Q4 2025, and down 713.0% year-over-year from 5.95% in Q1 2025.
Treace Medical Concepts (TMCI) Return on Capital Employed (2021 - 2026) Analysis & Trends
Treace Medical Concepts' Return on Capital Employed history runs 6 years deep, the most recent figure standing at 36.47% for Q1 2026.
- Quarterly Return on Capital Employed fell 713.0% year-over-year to 36.47% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 36.47% (down 713.0% YoY) and the FY2025 annual result came in at 31.27%, down 336.0% from the prior year.
- Return on Capital Employed was 36.47% for Q1 2026 at Treace Medical Concepts, down from 33.23% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 18.09% in Q1 2022 and bottomed at 36.47% in Q1 2026.
- A 5-year average of 27.73% and a median of 28.27% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed tumbled 2173 bps — and 2025, when it soared 503 bps.
- Treace Medical Concepts' Return on Capital Employed stood at 27.33% in 2022, then grew by 6 bps to 25.57% in 2023, then dropped by 21 bps to 30.92% in 2024, then retreated by 7 bps to 33.23% in 2025, then decreased by 10 bps to 36.47% in 2026.
- Business Quant data shows TMCI's Return on Capital Employed at 36.47% in Q1 2026, 33.23% in Q4 2025, and 30.16% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn | -36.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.47% |
| Dec 31, 2025 | -33.23% |
| Sep 30, 2025 | -30.16% |
| Jun 30, 2025 | -29.16% |
| Mar 31, 2025 | -29.34% |
| Dec 31, 2024 | -30.92% |
| Sep 30, 2024 | -34.36% |
| Jun 30, 2024 | -34.19% |
| Mar 31, 2024 | -28.27% |
| Dec 31, 2023 | -25.57% |
| Sep 30, 2023 | -22.73% |
| Jun 30, 2023 | -18.98% |
| Mar 31, 2023 | -22.41% |
| Dec 31, 2022 | -27.33% |
| Sep 30, 2022 | -27.37% |
| Jun 30, 2022 | -22.86% |
| Mar 31, 2022 | -18.09% |
| Dec 31, 2021 | -13.65% |
| Sep 30, 2021 | -5.63% |
| Jun 30, 2021 | -2.35% |